APC and cancer: SBS88 accounted for 64.3% of the colibactin-induced42APC splicing variant c.835-8A>G in colibactin-exposed samples, compared with only 3.9% and 3.8% of driver substitutions in APC or other cancer genes (Fig. 5e).